Pilot Study to Develop a Breath Analyser to Detect Chronic Kidney Disease
Pilot Study to Develop a Breath Analyser to Detect Chronic Kidney Disease
Measure trimethylamine oxide in the breath.
Organic compounds such as trimethylamine oxide (TMAO) accumulate in the blood of patients with kidney disease, and volatile compounds such as TMAO can be detected in the breath.
The investigators wish to develop a breath analyser to measure volatile compounds, such as TMAO in the breath in patients with kidney disease.
Inclusion Criteria:
Exclusion Criteria:
andrewdavenport@nhs.net442077940500